With Federal Nod, Consumers Could Lose The Boost They Get From Drug ‘Coupons’
The proposal being weighed by federal officials would allow employers and insurers to decide that drug companies’ assistance doesn’t count toward their members’ deductible or out-of-pocket maximum spending limits. If plans opted for that approach, only payments made by patients themselves would be included in the calculation toward reaching those limits.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed